New Rules Opening Access to Lab Test Results Will Empower Patients to Take Control of Their Health

5 Feb 2014
Sonia Nicholas
Managing Editor and Clinical Lead

Product news

Ruling Requires U.S. Laboratories to give Patient Access to Laboratory Test Reports

A final rule issued yesterday by the U.S. Department of Health and Human Services (HHS) giving Americans increased access to their personal health information will empower patients to exercise greater control over their health, according to Quest Diagnostics, the world's leading provider of diagnostic information services.

"Patient engagement is essential to creating a healthcare system that delivers better health outcomes at lower costs," said Jon Cohen, M.D., senior vice president and chief medical officer, Quest Diagnostics. "HHS's final rule means millions of Americans who previously could not access their laboratory and other health care data from clinical laboratory companies like Quest can now do so without first requiring the approval of their healthcare provider. That's a huge win for patients who want to take responsibility for their healthcare and engage in a richer dialogue with their providers in the interest of making informed clinical decisions."

The final rule amends the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations to give patients (or their representatives) direct access to the patient's laboratory test reports. At the same time, the final rule eliminates the exception under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule to an individual's right to access his or her protected health information when it is held by a CLIA-certified or CLIA-exempt laboratory that is prohibited by law from providing such access. In combination, these changes will require laboratories to provide patients access to their test reports. It does not require laboratories to interpret test results, and they may refer individuals back to their health provider for this information.

"Studies show that patients who have access to their health records tend to be more engaged in decision making than those who don't, and may even be more likely to follow treatment protocols and other behaviors that promote favorable outcomes," continued Dr. Cohen. "We're hopeful that the ruling will empower consumers to openly communicate with their physicians regarding tests, procedures and therapies, and actively participate in their healthcare."

Studies suggest that direct patient rights to healthcare information could improve patient participation in healthcare and possibly quality. A study in the Annals of Internal Medicine in 2009 found that patients were not informed of more than 7 percent of abnormal test results. Another study, published in Lab Medicine in 2007, found that "patients want information on their lab results" and suggests patients would be more satisfied with the healthcare system if given greater data access.

Quest Diagnostics provides patients several options for accessing their laboratory and other health data, including the company's Gazelle mobile health app for patients.

About Quest Diagnostics Healthcare IT Solutions

Quest Diagnostics is a provider of healthcare information technology solutions that facilitate secure, flexible data access and management to help improve patient care and lower healthcare costs. Care360 solutions are used by more than 310,000 physician users in more than 95,000 locations, providing a network of affiliated physician users in local communities and across the country. The Black Book award-winning Care360 EHR affordably and efficiently delivers laboratory, radiology, ePrescribing and other information to community providers.

Care360 EHR is certified under the Office of the National Coordinator's Authorized Testing and Certification Body (ONC-ATCB) program as meeting the requirements of the Health Information Technology for Economic and Clinical Health (HITECH) Act and its Meaningful Use provision. Quest Diagnostics HIT solutions also include the Gazelle mobile health app for patients and physicians and the award-winning ChartMaxx health document management solution. For more information, visit www.Care360.com or www.mygazelleapp.com.

Links

Tags

Blood TransfusionBlood Transfusion involves giving donor blood to a recipient patient. Screening is essential to avoid transfusion reactions. Blood banks use immunohematological techniques to determine rh and ABO blood group, and screen for antibodies using specific antisera. Blood Banks use Direct Coombs Tests (DCT) and Indirect Coombs Tests (IAT) to detect hemolysis and Haemolytic Disease of the Newborn (HDN).HematologyIn Haematology / Hematology, complete blood cell counts (or full blood counts) are obtained using automated blood count analyzers to enumerate blood cell types.  Hematology also encompasses haemostasis and coagulation, thrombophilia and hemophilia, plasma viscosity and ESR analysis, hemoglobinopathies, cell morphology and haematinic measurement.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Cellular PathologyCellular Pathology deals with the microscopic analysis of tissue samples and cells. Sample preparation and processing includes fixation, staining, sectioning and slide mounting, using equipment such microtomes and cryostats. In choosing immunohistochemistry and immunocytochemistry kits, consider chromogens, staining method, antibodies, microscopes and imaging.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Embryology / IVFEmbryology refers to the development of an embryo resulting from the fertilization of the ovum, to fetus stage. In vitro fertilization (IVF) refers to the fertilization of the egg outside of the human body, and is an important treatment for infertility.Healthcare IT Systems
New Rules Opening Access to Lab Test Results Will Empower Patients to Take Control of Their Health